Gut microbiome study for diarrhea after anti-cancer treatment
Part of Cancer clinical trials.
This trial looks at how changes in the gut (microbiome) relate to diarrhea that can happen after starting anti-cancer therapy. It may help doctors better predict and manage treatment-related diarrhea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Be about to start systemic anti-cancer treatment (anti-cancer therapy by mouth or through the body)
- Be able to give informed consent
- Do not have diarrhea before starting the trial (no pre-existing diarrhea)
- Do not have used antibiotics from 4 to 1 week before starting the trial
- Do not have used probiotics from 4 to 1 week before starting the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut bacteria might be connected to memory or thinking problems in people with cancer. If you join, you will answer surveys and provide stool samples to help researchers understand this link.
This study looks at your gut “microbiome” (the bacteria in your intestines) while you receive high-dose chemotherapy and a stem cell transplant, or CAR-T cell therapy. Researchers hope to understand how these treatments affect the microbiome, which may relate to how well patients do.
This study looks at how gut bacteria (the microbiome) change during treatment for colorectal cancer that has spread or cannot be removed. Researchers hope the findings may help improve understanding of how treatment works and how to tailor care.
This study looks at how gut bacteria may relate to how well immunotherapy works in people with advanced or returning gynecologic cancer. You may be asked to give stool samples several times so researchers can measure changes in your gut microbiome.
This study looks at how taking a probiotic supplement affects survival, treatment response, and gut bacteria in people undergoing cancer therapy. It may help you understand if adding probiotics can improve your treatment outcomes.
This study looks at how bacteria and other microbes in your gut are linked to colorectal cancer risk and outcomes. By collecting stool samples from people newly diagnosed with colorectal cancer, researchers hope to find patterns that could improve understanding and future treatments.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.